Correlation Between Health Biotchnology and Mid Capitalization

Can any of the company-specific risk be diversified away by investing in both Health Biotchnology and Mid Capitalization at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Health Biotchnology and Mid Capitalization into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Health Biotchnology Portfolio and Mid Capitalization Portfolio, you can compare the effects of market volatilities on Health Biotchnology and Mid Capitalization and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Health Biotchnology with a short position of Mid Capitalization. Check out your portfolio center. Please also check ongoing floating volatility patterns of Health Biotchnology and Mid Capitalization.

Diversification Opportunities for Health Biotchnology and Mid Capitalization

-0.52

Correlation Coefficient

Health Biotchnology  Mid Capitalization

Excellent diversification

The 3 months correlation between Health and Mid is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding Health Biotchnology Portfolio and Mid Capitalization Portfolio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mid Capitalization and Health Biotchnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Health Biotchnology Portfolio are associated (or correlated) with Mid Capitalization. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mid Capitalization has no effect on the direction of Health Biotchnology i.e., Health Biotchnology and Mid Capitalization go up and down completely randomly.

Pair Corralation between Health Biotchnology and Mid Capitalization

Assuming the 90 days horizon Health Biotchnology Portfolio is expected to under-perform the Mid Capitalization. But the mutual fund apears to be less risky and, when comparing its historical volatility, Health Biotchnology Portfolio is 1.27 times less risky than Mid Capitalization. The mutual fund trades about -0.1 of its potential returns per unit of risk. The Mid Capitalization Portfolio is currently generating about 0.26 of returns per unit of risk over similar time horizon. If you would invest  1,435  in Mid Capitalization Portfolio on September 2, 2024 and sell it today you would earn a total of  255.00  from holding Mid Capitalization Portfolio or generate 17.77% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Health Biotchnology Portfolio  vs.  Mid Capitalization Portfolio

Health Biotchnology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Health Biotchnology Portfolio has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong forward indicators, Health Biotchnology is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Mid Capitalization

Risk-Adjusted Performance

20 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Mid Capitalization Portfolio are ranked lower than 20 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak basic indicators, Mid Capitalization showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Health Biotchnology and Mid Capitalization

The main advantage of trading using opposite Health Biotchnology and Mid Capitalization positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Health Biotchnology position performs unexpectedly, Mid Capitalization can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mid Capitalization will offset losses from the drop in Mid Capitalization's long position.

The idea behind Health Biotchnology Portfolio and Mid Capitalization Portfolio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.